Hu Qingjiang 胡慶江

… Alternative Names

胡慶江フウチンジヤン

HU Qingjiang 胡慶江

Less

Researcher Number	80792902
Affiliation (Current)	2023: 九州大学, 医学研究院, 共同研究員
Affiliation (based on the past Project Information) *help	2023: 九州大学, 大学病院, 助教 2020: 九州大学, 大学病院, 助教 2019: 九州大学, 大学病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 50010:Tumor biology-related / Basic Section 55020:Digestive surgery-related
Keywords	Principal Investigator 胃癌 / 腫瘍学 / CYT / LOXL1 / OSBPL3 / 免疫チェックポイント / 癌遺伝子 / 腫瘍局所環境 / 増殖能 / 細胞周期 … More / RRAS / RNA-seq / in silico解析 / Xenograft mouse / 新規癌遺伝子 / 新規治療標的 / NGS解析 Less

マクロファージ免疫チェックポイント阻害による新規食道癌治療法の基礎研究Principal Investigator
- Principal Investigator
  
  胡慶江
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 55020:Digestive surgery-related
- Research Institution
  Kyushu University
The biological and clinical significance of the novel GC oncogenes that were identified by in silico analysisPrincipal Investigator
- Principal Investigator
  
  HU Qingjiang
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50010:Tumor biology-related
- Research Institution
  Kyushu University

All 2021 2020 2019

All Journal Article Presentation

[Journal Article] Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.2021
- Author(s)
  Qingjiang Hu 1 , Kentaro Nonaka 1 , Hiroaki Wakiyama 2 , Yu Miyashita 1 , Yoshiaki Fujimoto 1 , Tomoko Jogo 1 , Kentaro Hokonohara 1 , Ryota Nakanishi 1 , Yuichi Hisamatsu 1 , Koji Ando 1 , Yasue Kimura 1 , Takaaki Masuda 2 , Eiji Oki 1 , Koshi Mimori 2 , Yoshinao Oda 3 , Masaki Mori 1
- Journal Title
  
  Cancer Med.
  
  Volume: - Pages: 3129-3138
- DOI
  10.1002/cam4.3828
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K16718, KAKENHI-PROJECT-19K09176, KAKENHI-PUBLICLY-20H05039, KAKENHI-PROJECT-19H03715
[Journal Article] Reintroduction of nivolumab in a patient with gastric cancer after improvement of nivolumab-induced acute interstitial nephritis: a case report2020
- Author(s)
  Qingjiang Hu 1 , Hirofumi Hasuda 1 , Kenji Ueki 2 , Akihiro Tsuchimoto 2 , Yoko Zaitsu 1 , Yasuo Tsuda 1 , Yuichi Hisamatsu 1 , Yuichiro Nakashima 1 , Koji Ando 1 , Yasue Kimura 1 , Eiji Oki 1 , Masaki Mori 1
- Journal Title
  
  Int Cancer Conf J.
  
  Volume: 9 Pages: 127-132
- DOI
  10.1007/s13691-020-00418-2
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K16718
[Journal Article] Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.2020
- Author(s)
  Hu, Q, Masuda T et al
- Journal Title
  
  PLoS One
  
  Volume: 15
- DOI
  10.1371/journal.pone.0241140
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09176, KAKENHI-PUBLICLY-20H05039, KAKENHI-PROJECT-19H03715, KAKENHI-PROJECT-18K08649, KAKENHI-PROJECT-19K16718
[Presentation] 当科での使用経験から見た胃癌に対するニボルマブの臨床意義2021
- Author(s)
  蓮田　博文、胡　慶江
- Organizer
  第76回消化器外科学会
- Data Source
  KAKENHI-PROJECT-19K16718
[Presentation] LOXL1 is a novel responsible gene for peritoneal dissemination potentially via promoting EMT and motility in gastric cancer2020
- Author(s)
  Qingjiang Hu
- Organizer
  AACR
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K16718
[Presentation] Potential association of LOXL1 with peritoneal dissemination in gastric cancer via promotion of EMT2020
- Author(s)
  胡　慶江
- Organizer
  第120回日本外科学会
- Data Source
  KAKENHI-PROJECT-19K16718
[Presentation] LOXL1 is a novel responsible gene for peritoneal dissemination potentially via promoting EMT and motility in gastric cancer2019
- Author(s)
  Qingjiang Hu
- Organizer
  7th international Conference of Federation of Asian Clinical Oncology (FACO)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K16718

1. 増田隆明

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
2. 三森功士

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
3. 黒田陽介

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Hu Qingjiang 胡 慶江

胡 慶江 フウ チンジヤン

HU Qingjiang 胡 慶江

Research Projects

Research Products

Co-Researchers

マクロファージ免疫チェックポイント阻害による新規食道癌治療法の基礎研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The biological and clinical significance of the novel GC oncogenes that were identified by in silico analysisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Cytolytic activity score as a biomarker for antitumor immunity and clinical outcome in patients with gastric cancer.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Reintroduction of nivolumab in a patient with gastric cancer after improvement of nivolumab-induced acute interstitial nephritis: a case report2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.2020

Author(s)

Journal Title

DOI

Data Source

[Presentation] 当科での使用経験から見た胃癌に対するニボルマブの臨床意義2021

Author(s)

Organizer

Data Source

[Presentation] LOXL1 is a novel responsible gene for peritoneal dissemination potentially via promoting EMT and motility in gastric cancer2020

Author(s)

Organizer

Data Source

[Presentation] Potential association of LOXL1 with peritoneal dissemination in gastric cancer via promotion of EMT2020

Author(s)

Organizer

Data Source

[Presentation] LOXL1 is a novel responsible gene for peritoneal dissemination potentially via promoting EMT and motility in gastric cancer2019

Author(s)

Organizer

Data Source

Hu Qingjiang 胡慶江

胡慶江フウチンジヤン

HU Qingjiang 胡慶江